The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

 

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”.

 


The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:

§  A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.

§  A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications.

§  An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters.

§  A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future.

§  Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products).

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Global Novel Vaccine Delivery Devices (By Value)  

§  Type of Device

        Electroporation-based Needle Free Injection Systems

        Oral Delivery Systems

        Nasal Delivery Systems

        Jet Injectors

        Microneedle Patches

        Microinjectors

 

§  Route of Administration

        Oral

        Intramuscular

        Intranasal

        Intradermal

        Subcutaneous

 

§  Type of Vaccines

        Bivalent Oral Polio Vaccine

        BCG Vaccine

        DTP-HepB-Hib Vaccine

        Pneumococcal Conjugate Vaccine

        Influenza Vaccine

        Measles Vaccine

        Tetanus-Diphtheria Vaccine

        Others

 

§  Key Geographical Region

§  North America

§  Europe

§  Asia Pacific

§  Rest of the World

 

Key companies covered in the report

§  3M

§  Becton Dickinson

§  Consort Medical

§  D’Antonio Consultants International

§  Enesi Pharma

§  Ichor Medical

§  Iconovo

§  Inovio Pharmaceuticals

§  PharmaJet

§  Union Medico

 

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.      Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

2.     Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

3.       Large Volume Wearable Injectors Market (4th Edition), 2018-2030

4.       Global Autoinjectors Market (2nd Edition), 2018-2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com


Contact Details

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com


Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers

Image
Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions Roots Analysis has announced the addition of the “ On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles ” report to its list of offerings.   Since the early 20th century, over 12,000 patents / patent applications have been granted / filed in relation to drug delivery devices that can either be worn on the body ( or implanted ), by both industry and non-industry players. Presently, innovation in this domain is focused on developing cheaper and more environment friendly drug delivery systems, with provisions to minimize / altogether eliminate the risk of needlestick injuries. ...
Read more

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

Image
To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §   A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of administration (intravenous, subcutaneous, oral and others), target disease indication, target therapeutic area and type of therapy (monotherapy, combination therapy and both).  §   A detailed analysis of more than 590 completed, ongoing and planned clinical studies of next generation immune checkpoint inhibitors and stimulators, highlighting prevalent trends across various relevant paramete...
Read more

The CAR-T cell therapy market is estimated to be worth USD 14 billion in 2030, predicts Roots Analysis

Image
  Given their ability to selectively direct a cell mediated immune response against cancer cells and, thereby, offer prolonged periods of disease remission, several CAR-T cell therapies are expected to achieve blockbuster status   Roots Analysis is pleased to announce the publication of its recent study, titled, “ CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2021-2030 ”   The features an extensive study of the current market landscape and the future potential of CAR-T cell therapies. The report highlights the efforts of both industry players and acade...
Read more